Robert L. Coffman
2017
In 2017, Robert L. Coffman earned a total compensation of $2M as Senior Vice President and Chief Scientific Officer at Dynavax Technologies, a 70% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $297,582 |
|---|---|
| Salary | $466,796 |
| Stock Awards | $1,223,041 |
| Other | $2,000 |
| Total | $1,989,419 |
Coffman received $1.2M in stock awards, accounting for 61% of the total pay in 2017.
Coffman also received $297.6K in non-equity incentive plan, $466.8K in salary and $2K in other compensation.
Rankings
In 2017, Robert L. Coffman's compensation ranked 5,522nd out of 14,666 executives tracked by ExecPay. In other words, Coffman earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,522 out of 14,666 | 62nd |
Division Manufacturing | 1,992 out of 5,768 | 66th |
Major group Chemicals And Allied Products | 605 out of 2,074 | 71st |
Industry group Drugs | 466 out of 1,730 | 73rd |
Industry Pharmaceutical Preparations | 364 out of 1,329 | 73rd |
Source: SEC filing on April 20, 2018.
Coffman's colleagues
We found four more compensation records of executives who worked with Robert L. Coffman at Dynavax Technologies in 2017.